Cetera Trust Company’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$492K Hold
4,670
– – 0.25% 77
2026
Q2
$350K Buy
4,670
+220
+5% +$14.1K 0.18% 109
2026
Q1
$251K Hold
4,450
– – 0.14% 134
2025
Q4
$357K Buy
4,450
+75
+2% +$5.04K 0.19% 91
2025
Q3
$213K Buy
+4,375
New +$271K 0.12% 159

Other funds holding HAE

Cetera Trust Company's HAE Position: Q3 2026 in Review

Cetera Trust Company held its Haemonetics (HAE) position steady in Q3 2026 at 4,670 shares worth $492K. The position accounts for 0.25% of the portfolio, ranked #77.

Cetera Trust Company first reported a position in HAE in Q3 2025 and has held it in 5 quarters since. 361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Cetera Trust Company held 4,670 shares of Haemonetics worth $492K as of Q3 2026.
  • Cetera Trust Company left its Haemonetics share count unchanged in Q3 2026.
  • Haemonetics made up 0.25% of Cetera Trust Company's portfolio in Q3 2026, its #77 holding.
  • Cetera Trust Company first reported a position in Haemonetics in Q3 2025 and has held it in 5 quarters since.
  • 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Cetera Trust Company's 13F filing for Q3 2026, filed 9 Nov 2026.